期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非小细胞肺癌的预后因素分析 被引量：3

Prognostic analysis of non-small lung cancer
下载PDF
导出
摘要 肺癌的发病率和死亡率逐年增加,其中80%-85%为非小细胞肺癌(NSCLC),其预后较差,长期生存率低,是我国目前的第一大癌症。影响其预后的因素很多,加强对预后因素的研究对制定个体化的治疗方案尤为重要,本文回顾近几年关于NSCLC预后方面的研究进展。
作者 王琴 展平 宋勇
机构地区 解放军第八一医院呼吸科 南京军区南京总医院呼吸科
出处 《中国肺癌杂志》 CAS 2008年第4期598-601,共4页 Chinese Journal of Lung Cancer
关键词 预后因素 治疗方案 文献报道 NSCLC 小细胞肺癌
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献4

  • 1刘树库,许绍发,刘志东,吴纪峰,李福根,韩毅.不同年龄段非小细胞肺癌的外科临床特点及预后[J].中国肺癌杂志,2007,10(5):418-421. 被引量：15
  • 2黄逸生,吴一龙,杨学宁,杨衿记,廖日强.新辅助化疗对非小细胞肺癌预后影响的Meta分析[J].循证医学,2005,5(3):147-155. 被引量：11
  • 3Noriyoshi Sawabata MD,Shinichiro Miyoshi MD,Akihide Matsumura MD,Mitsunori Ohta MD,Hajime Maeda MD,Hirofumi Sueki MD,Masanobu Hayakawa MD,Meinoshin Okumura MD,Yoshiki Sawa MD. Prognosis of smokers following resection of pathological stage I non-small-cell lung carcinoma[J] 2007,General Thoracic and Cardiovascular Surgery(10):420～424
  • 4Takeshi Hanagiri,Kenji Sugio,Hidetaka Uramoto,Tetsuya So,Yoshinobu Ichiki,Masakazu Sugaya,Kenji Ono,Manabu Yasuda,Tadahiro Nozoe,Kosei Yasumoto. Gender Difference as a Prognostic Factor in Patients Undergoing Resection of Non-Small Cell Lung Cancer[J] 2007,Surgery Today(7):546～551

二级参考文献28

  • 1姚珂,向明章,闵家新,张国强,周人杰,李德志.Ⅲ期非小细胞肺癌术前新辅助化疗的随机对照临床试验[J].中国肿瘤临床,2004,31(11):611-613. 被引量：19
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量：869
  • 3吴一龙.手术治疗在肺癌多学科综合治疗中的作用[M]//吴一龙主编.肺癌多学科综合治疗的理论和实践.北京:人民卫生出版社,2000:59-60.
  • 4Rosell R, Gomez-Condina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer [J]. N Engl JMed, 1994,330:153-158.
  • 5Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage ⅢA non-small cell lung cancer [J]. JNatl Cancer Inst, 1994,86:673-680.
  • 6Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage ⅠⅡⅢ A non-small-cell lung cancer [J]. J Clin Oncol, 2002,20(1):247-253.
  • 7Nagai K, Tsuchiya R, Mori T, et al. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage Ⅲ A N2 non-small cell lung cancer(JCOG9209) [J]. J Thorac Cardiovasc Surg, 2003:125:254-260.
  • 8吴一龙.肺癌的国际分期[M]//吴一龙主编.肺癌多学科综合治疗的理论和实践.北京:人民卫生出版社,2000:25-26.
  • 9张博恒.Meta分析中统计学方法[M]//王吉耀主编.循证医学与临床实践.北京:北京科学出版社,2002,1:86-110.
  • 10刘建平.系统综述[M]//王吉耀主编.循证医学与临床实践.北京:北京科学出版社,2002:56-61.

共引文献24

同被引文献32

  • 1Hudon C, FortinM, Soubhi H. Abbreviated guidelines for scoringthe Cumulative Illness Rating Scale (CIRS) in family practice [ J]. J Clin Epidemiol,2007,60(2) :212-212
  • 2Wedding U, Roehrig B, Klippstein A, et al. Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale [ J]. Crit Rev Oncol Hematol,2007,61 (3): 269 -276.
  • 3Hudon C, Fortin M, Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in a family practice context [ J ]. J Clin Epidemiol, 2005,58 ( 6 ) :603-608.
  • 4Linn BS, Linn MW, Gurel L. Cumulative illness rating scale[ J]. J Am Geriatr Soc, 1968,16(5 ) :622-626.
  • 5Birim O, Kappetein AP, van Klaveren R J, et al. Prognostic factors in nonsmall cell lung cancer surgery[ J]. Eur J Surg Oncol, 2006, 32(1) : 12-23.
  • 6Mandrekar S J, Schild SE, Hillman SL, et al. A prognostic model foradvanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials[ J]. Cancer, 2006, 107(4) : 781-792.
  • 7Firat S, Byhardt RW, Gore E. Comorbidity and Karnofksy performance score are independent prognostic factors in stage Ⅲ non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies[ J]. Int J Radiat Oncol Biol Phys, 2002, 54(2) : 357-364.
  • 8Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual,seventh edition[M]. New York: Spinger, 2010: 251- 254.
  • 9Hudon C, Fortin M, Soubhi H. Abbreviated guidelines for scoring the Cumulative Illness Rateing Scale (CIRS) in family practice[J]. J Clin Epidemiol, 2007,60 (2) : 212.
  • 10Gridelli C, Bareschino MA, Schettino C. Erlotinib in non-small cell lung cancer treatment: current status and future development[-J]. Oncologist, 2007,12 (7) : 840-849.

引证文献3

中国肺癌杂志
2008年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部